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Abstract
Background: Although the increasing availability of mobile health (mHealth) apps may enable people with rheumatic and
musculoskeletal diseases (RMDs) to better self-manage their health, there is a general lack of evidence on ways to ensure
appropriate development and evaluation of apps.
Objective: This study aimed to obtain an overview on existing mHealth apps for self-management in patients with RMDs,
focusing on content and development methods.
Methods: A search was performed up to December 2017 across 5 databases. For each publication relevant to an app for RMDs,
information on the disease, purpose, content, and development strategies was extracted and qualitatively assessed.
Results: Of 562 abstracts, 32 were included in the analysis. Of these 32 abstracts, 11 (34%) referred to an app linked to a
connected device. Most of the apps targeted rheumatoid arthritis (11/32, 34%). The top 3 aspects addressed by the apps were
pain (23/32, 71%), fatigue (15/32, 47%), and physical activity (15/32, 47%). The development process of the apps was described
in 84% (27/32) of the articles and was of low to moderate quality in most of the cases. Despite most of the articles having been
published within the past 2 years, only 5 apps were still commercially available at the time of our search. Moreover, only very
few studies showed improvement of RMD outcome measures.
Conclusions: The development process of most apps was of low or moderate quality in many studies. Owing to the increasing
RMD patients’ willingness to use mHealth apps for self-management, optimal standards and quality assurance of new apps are
mandatory.
(JMIR Mhealth Uhealth 2019;7(11):e14730)  doi: 10.2196/14730
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Introduction
Background
Mobile health (mHealth) connects patients, their families, and
health care professionals by creating a network with mobile and
specialized devices with wearable sensors, recording health
parameters, and gathering health data. Health information can
be subsequently converted and transferred to physicians and
other health care professionals involved in the care of patients
via medical application interfaces. By enabling patients to access
and share their health information, mHealth empowers patients
to become more engaged and to take initiative in
self-management and shared management of their health.
Since the first description of the concept of mHealth [1], its
popularity has exponentially increased. This is primarily because
of the fast expanding technological advances including the
development of smartphones and fourth generation mobile
communication system networks. The impressive popularity of
mHealth apps in the last decade is reflected by the number of
downloads in recent years, exceeding 200 million in 2010 [2].
On the wider mHealth market, various apps have been developed
for different purposes. The latter include apps for disease
prevention among healthy users [3] and apps for people with
existing chronic health conditions [4]. A recent study, for
example, demonstrated that apps can contribute to improve
disease control in people with diabetes [5], hypertension [6], or
asthma [7] and can help for the monitoring and self-management
of obesity [8], mental health diseases [9], and multimordbidities
[10]. A total of 17.3 million people report having rheumatic and
musculoskeletal diseases (RMDs), the most frequent being low
back pain and osteoarthritis (OA) [11]. As RMDs have
multidimensional consequences on health, the increasing
availability of apps has an important role to play in enabling
people with RMDs to better self-manage their health [12].
Moreover, in a recent study of people with rheumatoid arthritis
(RA), 86% agreed that an app to support self-management would
be useful and welcomed [13]. This being said, the dramatic
increase and adoption of mHealth apps and the business it
generates raise some fundamental questions, such as (1) How
is the scientific content controlled? and (2) How can we make
sure that apps are appropriate for patients?
Objectives
Despite the growing enthusiasm for this topic among physicians
and researchers, there is a lack of evidence describing the
development and evaluation of apps for people with RMDs that
fulfill quality requirements for their implementation as part of
routine care. This formed the rationale for this systematic review
of literature as part of a larger project to inform points to
consider for the development, evaluation, and implementation
of mHealth apps for self-management of RMDs. The
overarching aim of this systematic review was to obtain a clear
view on existing mHealth apps for patients with RMD. Specific
objectives were to better characterize (1) the target population
of available apps, (2) their purpose and content, and (3)
strategies of mHealth app development.
Methods
Search Strategy
A systematic literature review (SLR) was performed following
the preferred reporting items for systematic reviews and
meta-analyses methodology [14]. The search was performed
using the Cochrane Library, EMBASE, MEDLINE, PsychINFO,
Web of Science, and gray literature (internet and international
rheumatology societies’ websites) up to December 2017.
Relevant keywords and Medical Subject Headings terms relative
to 3 key domains were used: RMDs, self-management, and
mHealth (see Multimedia Appendices 1 and 2). The search
strategy was developed with support from 2 experienced
librarians (DB and CW). The clinical questions and inclusion
criteria were predefined according to the population,
intervention, control, and outcomes (PICO) statement [15].
PICO is a framework that allows to facilitate literature search
and to formulate the scientific questions. The target population
was patients with any RMDs. The intervention was the
description or use of any apps for self-management, irrespective
of whether these apps were connected or not to a device.
Any articles describing the development, evaluation, usability,
accessibility, effectiveness, and assessment of patient-reported
outcomes (PROs) collected through the internet or through
electronic apps, and satisfaction over the use of an app for
disease self-management, were included. English language was
applied as a limit for the articles. Double screening by 2
independent reviewers (AN and EN) was performed for all
abstracts against inclusion/exclusion criteria with agreement of
99% in selected papers. Disagreements were resolved by
discussion.
Data Analysis
Data regarding type of app, target population, country of
development, themes and objectives, development process,
funding sources, and functionality of the app were collected.
The development process was classified into 3 main categories:
(1) patients or health care providers involved in both design and
evaluation phases, (2) patients or health care providers involved
in the evaluation but not in the design process, and (3) neither
patients nor health care providers involved in the design or
evaluation phases.
The commercial availability of the app was also checked on
Google and Apple Store. Owing to the vast heterogeneity of
the included studies, a meta-analysis was not considered
appropriate. Descriptive statistics were performed using
GraphPad Prism (GraphPad Software, San Diego)
Results
Systematic Literature Search Output
The search identified 562 abstracts. Manual search through
screening of national societies and patient associations’ home
pages yielded 1 additional reference. After duplicate exclusion,
475 abstracts were screened based on title and abstract. From
these, 56 articles were identified as potentially relevant and
selected for full-text assessment. After full-text assessment, 32
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articles were considered suitable for inclusion in the analysis (Figure 1).
Figure 1. Flow chart summary of the systematic literature review, article identification, screening, and final selection. mHealth: mobile health.
General Study Characteristics
Out of the 32 included studies, 28 were observational studies
and 4 were randomized controlled trials (RCTs). Description
of the objective for each study, the target disease, the country
of origin, name of the app, and the type of data collected by the
app of each RCT [16-21] and observational studies [22-47] is
detailed in Multimedia Appendix 3 [48].
Target Disease of Mobile Health Apps, Country of
Origin, and Funding Sources
Out of the 32 included articles, 13 (40%) referred to an app
linked to a connected device. Most of the apps (26/32, 81%)
were designed for the use of patients living with a specific
rheumatic disease, distributed as follows: RA (11/32, 34%),
fibromyalgia (5/32, 15%), juvenile idiopathic arthritis (4/32,
12%), OA (3/32, 9%), psoriatic arthritis and ankylosing
spondylitis (AS; 1/32, 3%), spine disease (1/32, 3%), and ankle
sprain (1/32, 3%). The other apps (6/32, 18%) were either
designed for multiple diseases (eg, AS, RA, and systemic lupus
erythematosus) or for the general population but used by patients
living with RMDs in some studies. The great majority of the
apps were developed in the United States (11/32, 34%), Japan
(4/32, 12%), Canada (3/32, 9%), and Norway (3/32, 9%).
The funding sources were cited in 93% (30/32) of the articles
and reported to be private in 34% (11/32) of the cases. The
funding source was reported to be academic in 62% (20/32) of
the articles.
Purposes and Data Collected by Mobile Health Apps
Most of the apps were designed for self-monitoring and
collection of specific outcome measures (22/32, 68%), the latter
including patient-reported outcome measures (pain, fatigue,
sleep, mood, and global well-being) and disease activity scores.
Furthermore, many allowed self-visualization of the health data
as a trend (17/22, 77%), such as disease activity scores and
physical activity (measured by the number of steps). A few apps
(7/32, 21%) aimed to promote physical activity through daily
reminders and education on physical activity programs. For
instance, 2 apps were designed to support coping mechanisms
around pain management with relaxation therapy. Finally, 2
apps were designed primarily to help medication adherence
through a tick-box option on the app when the medication is
taken or through sending daily reminders with the possibility
for the patient to edit the frequency of the reminders. None of
the apps were reported as having the status of medical device.
Most of the apps addressed multiple disease features (detailed
in Table 1).
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Table 1. Features addressed by the different apps for rheumatoid arthritis and other rheumatic and musculoskeletal diseases.
Apps designed for other rheumatic and musculoskeletal diseasesRheumatoid arthritis appsFeatures addressed by the apps
Details on other diseasesValue, n (%)Value, n (%)
JIAa, OAb, fibromylagia, PsA/ASc, and spine disease13 (41)7 (22)Pain
JIA, OA, and fibromylagia9 (28)4 (13)Fatigue
JIA and OA9 (28)2 (6)Physical activity
JIA, OA, and fibromylagia8 (25)1 (3)Sleep
PsA/AS1 (3)8 (25)Disease Activity Score
JIA and PsA/AS2 (6)6 (19)Health Assessment Questionnaire
JIA, OA, and fibromylagia6 (19)0 (0)Mood
OA6 (19)1 (3)Global well-being (Short Form 36)
JIA and PsA/AS4 (13)1 (3)Morning stiffness
Fibromyalgia2 (6)1 (3)Depression/anxiety
JIA, OA, and fibromylagia3 (9)1 (3)Medication/adherence
JIA3 (9)1 (3)Tender joint count
—
d0 (0)4 (13)Gait
JIA2 (6)0 (0)Social support
JIA2 (6)0 (0)Work
—0 (0)1 (3)Grip
aJIA: juvenile idiopathic arthritis.
bOA: osteoarthritis.
cPsA/AS: psoriatic arthritis/ankylosing spondyloarthritis.
dNot applicable.
Development Process of the Apps
The development process of the app was not described at all in
9% (3/32) of the studies (Table 2). Only 15% (5/32) of articles
stated that patients were included in the development of the
apps. A qualitative phase occurred in only 18% (6/32) of the
cases [19,27,30,33,36,37]. This qualitative phase consisted of
individual interviews (4 different studies), patient focus group
(1 study), or patients focus groups and individual interviews (1
study). A mixed method approach was undertaken in 2 of those
studies, with the addition of a patient survey or a Delphi
procedure.
Health professionals and/or physicians were involved in the
development or evaluation phase in 40% (13/32) of the studies.
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Table 2. Description of the development phase and funding sources of the apps.
Funding/developmentQualitative phasePatient involve-
ment
Health care
provider involve-
ment
Quality of design and
evaluation phase
Reference
PrivateN/AN/AN/AN/AaLi et al, 2017 [16]
Private−+d−cBbSkrepnik et al, 2017 [17]
Public++−AeKristjansdottir et al, 2013 [18]
Public++−AKristjansdottir et al, 2013 [19]
Private−+−BPaxton et al, 2018 [20]
Private−+−BHarmelink et al, 2017 [21]
Public−+−BBults et al, 2010 [22]
Public−+−BKvien et al, 2005 [23]
Not reported−+−BHeiberg et al, 2007 [24]
Public−++BRichter et al, 2008 [25]
Public+++AStinson et al, 2008 [26]
Public+++AStinson et al, 2006 [27]
Public−++BGarcia-Palacios et al, 2014 [28]
Public−+−BNishiguchi et al, 2016 [29]
Public+++Ade la Vega et al, 2018 [30]
Private−+−BSalaffi et al, 2013 [31]
Public−++BYen et al, 2016 [32]
Private++−AKhurana et al, 2016 [33]
Public−+−BKim et al, 2016 [34]
Public+++ACai et al, 2017 [35]
Public and private+++ARevenas et al, 2015 [36]
Public−++BSynnott et al, 2015 [37]
Public−+−BBromberg et al, 2016 [38]
Public−+−BBromberg et al, 2014 [39]
Private−+−BOkifuji et al, 2011 [40]
Public−++BNishiguchi et al, 2014 [41]
Not reported−+−BShinohara et al, 2013 [42]
Private−++BWalker et al, 2017 [43]
Public−+−BYamada et al, 2012 [44]
PrivateN/AN/AN/AN/AEspinoza et al, 2016 [45]
Public−++BKim et al, 2016 [46]
PrivateN/AN/AN/AN/ATwiggs et al, 2018 [47]
aNot applicable.
bPatients or health care providers involved in the evaluation but not in the design process.
cAbsent.
dPresent.
ePatients or health care providers involved in both design and evaluation phases.
Evaluation of the Apps
Physicians were rarely involved in app evaluation (5/32, 15%).
Patients were more frequently involved in app evaluation but
mostly indirectly through their adherence to the app (12/32,
70%). A total of 17 apps proposed a direct evaluation through
the use of a satisfaction scale (12/32, 70%) and/or an open or
closed questionnaire (9/32, 52%). Satisfaction scores and
comments were generally positive.
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Commercial Availability of the Apps
Moreover, 16 (50%, 16/32) articles included in this review were
published between 2016 and 2017. Only a few apps described
in the publications were commercially available (4/32, 12%) at
the time of our web-based search; all were free of cost.
Quality of the Available Apps
We performed quality score on the apps, which were existing
in the different online stores (iTunes and Google Play) using a
validated app quality score, the Mobile Application Rating Scale
(MARS) [48]. The MARS includes different quality subscale
scores, which rate engagement, functionality, aesthetics, and
information. The score was calculated for the available apps.
MARS for the ReaApp (Google Play) was 3.01 out of 5 and 3.8
out of 5 for the iGetBetter app (iTunes). The other apps were
either not available online (28/32) or not in English language
(1/32) or not accessible for free (1/32).
Effectiveness of the Apps
A total of 2 RCTs were included in the SLR, 1 study in OA [17]
and 1 in fibromyalgia [18,19]. In the trial by Skrepnik et al [17],
patients were randomized in 2 groups: a mobile OA app along
with a wearable activity monitor with (intervention group) or
without feedback (control group). A significant increase in the
number of steps per day (1199 vs 467, P=.03) as well as a
reduction in pain from baseline during the 6-min walk test was
shown in the intervention group. The trial by Kristjandottir et
al [19] included a smartphone-delivered intervention with diaries
and personalized feedback to patient living with fibromyalgia.
The primary endpoint was met with a reduction of
catastrophizing score in the treated group (mean 9.20, SD 5.85)
compared with the control group (mean 15.71, SD 9.11;
P<.001).
Discussion
Principal Findings
To our knowledge, this is the first piece of work to identify
literature published on self-management mHealth apps for
patients living with RMDs. Our search yielded heterogeneous
studies, referring to heterogeneous apps designed either for a
specific rheumatic disease or for multiple diseases and also for
the general public/healthy population. The large quantity and
variety of information that was collected by the app and the
relevance of collecting this information as part of a
self-management initiative are questionable and not always
clearly outlined.
The development process of most apps has been insufficient or
not described in the screened existing literature, which raises
questions around their credibility. Importantly, most of the apps,
despite being designed for patient use, involved neither patients
nor health care providers in their development phase. These
findings are in line with recently published work, showing that
health care professionals were involved in only 35% (n=7) of
the apps designed for RA patients [49]. This is a major concern
as the absence of involvement of the relevant stakeholders might
lead to inappropriate development tailored for the eventual user,
including lack of assurance of content approval by specialists.
Our results highlight the unmet need for a standardization
process to facilitate the convoluted and demanding processes
required to develop mHealth apps. This matter goes beyond the
scope of self-management apps for patients. For instance,
Buijink et al [50] showed in a previous study that most mHealth
apps designed for health care professionals were lacking
authenticity details; authors, manufacturers, and distributors
were not listed; and references were unavailable or out of date.
Indeed, as mHealth apps are considered as medical devices by
the US Food and Drug Administration, they should be subject
to rigorous regulation [50]. These findings are consistent with
our own findings and observations; indeed, the provenance and
design process of the app as well as developers and funding
sources are lacking details in many papers. Indeed, funding
sources were not cited in more than half of the studies, which
makes it difficult to identify clearly the nature of beneficiaries
of such apps.
Moreover, despite more than half of the studies included in this
review being published in the past 2 years, only a handful of
apps were commercially available at the time of our search.
This highlights the high turnover of apps developed for this
purpose. One speculation could be that some of the apps were
used in only 1 center and therefore have never been available
for public use.
Strengths and Limitations
It should be noted that our systematic review did not specifically
address the question of reviewing apps existing in the Apple
store. We focused on published literature on self-management
mHealth apps, regardless of the type of RMDs. The very
heterogeneous nature of the literature published on this topic
and the relatively low number of relevant publications on the
subject constitute the main limitations of this study. To ensure
a most informative literature review, aside from systematically
exploring the literature and other possible sources of
information, we extracted data from the apps’ content and
development procedure when it was provided. The latter
revealed that many apps were usually focusing on selected
aspects of disease self-management. Most were giving the
patients the opportunity to enter selected PROs, especially
fatigue, pain, and sleep, and also collected information on
physical activity. Disease activity scores were more rarely
(28.2%) collected by the apps. No relevant data were available
on the quantitative use of apps.
Our work is in line with a recent study by Grainger et al who
assessed the quality of RA apps specifically, highlighting the
fact that of the 19 apps analyzed, only 1 had functionality to
allow both the calculation of a validated composite disease
activity measure and the ability to track calculated patient data
[51]. Another recent work showed that most of the apps designed
for patients living with RA did not offer a comprehensive
experience. Comparably with what we found in the literature,
not all apps (75%) offered a symptom tracking experience, and
when it was the case, only a few apps allowed collecting PROs,
joint counts, and laboratory results [49].
Thinking forward, a development process under specific
guidelines or recommendations is mandatory to improve
physicians’ as well as patients’ confidence in future apps.
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Having a meticulous development process in place can enhance
appropriateness for the specific purpose they have been designed
for, their scientific content and accuracy. By regulating the
development process, the health care providers will also validate
reliability of the scientific content and regulatory rules to ensure
data protection and patient safety.
Conclusions
In conclusion, despite patient willingness to use mHealth apps
for self-management of their RMDs, better endeavors are needed
to provide an optimal standard and ensure the quality and safety
of new apps. This work will be used to further inform European
League Against Rheumatism (EULAR) points to consider for
development, evaluation, and implementation of mHealth apps
for self-management of RMDs by patients. We hope through
this work to stimulate some careful considerations around
mHealth app development and evaluation, which will lead to a
general effort to improve their value.
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